Fact-checked by Grok 2 weeks ago

Actimel

Actimel is a fermented dairy drink produced by the French multinational , containing the strain Lactobacillus casei DN-114 001 (also known as L. casei Imunitass), along with vitamins D and B6, and marketed primarily for supporting immune health. Launched in in 1994 following research into fermented milks with L. casei strains initiated in the 1980s, Actimel expanded rapidly across and beyond, becoming a leading shot in over 26 countries by emphasizing its exclusive bacterial cultures designed to survive . The product is available in various flavors, typically in small 100ml bottles, and has been positioned as a daily immune booster, with sales driven by claims of billions of live cultures per serving. While some clinical trials have indicated potential benefits, such as reducing antibiotic-associated diarrhea, regulatory assessments have found insufficient evidence to substantiate broader immunity-enhancing claims specifically attributable to the probiotic strain in Actimel. The (EFSA) rejected 's health claim application for L. casei DN-114 001 in 2010, concluding no cause-and-effect relationship for immune function beyond the established roles of vitamins D and B6. This led to controversies, including bans on misleading promotions implying prevention of infections in children, prompting to withdraw certain unsubstantiated claims. Independent reviews have similarly critiqued the scientific support for advertised benefits, highlighting that probiotic efficacy in commercial drinks often lacks robust, generalizable data.

Product Overview

Composition and Formulation

Actimel is a fermented dairy drink produced from as the primary base, combined with cultures including Lactobacillus bulgaricus and , and fortified with the probiotic strain Danone (also designated L. casei DN-114001). Additional core ingredients in the original formulation include sugar or liquid sugar, dextrose, and milk minerals concentrate, with vitamins B6 and added post-fermentation to enhance nutritional profile. The product is designed to deliver at least 10 billion live L. casei cultures per 100 ml serving, enabling the strain to survive gastric acidity and reach the intestines. The nutritional composition per 100 g serving typically provides 303 kJ (72 kcal) of , 2.8 g of protein, 1.5 g of (with 1.0 g saturated), 11 g of sugars, and 0.10 g of salt, alongside the specified vitamins contributing to daily requirements (e.g., 100% of reference intake). Variants may incorporate purées (e.g., 2.1% from concentrates like or ), oligofructose for , or stabilizers like , while low-sugar or fat-free versions replace sugars with sweeteners such as or acesulfame K. Formulation begins with of , followed by with standard ferments and L. casei , then subjected to a proprietary slow-fermentation process exceeding eight hours at controlled temperatures to optimize viability and culture density, distinguishing it from conventional with shorter . Post-fermentation, the mixture is homogenized, fortified with vitamins and minerals, and aseptically filled into single-serve bottles to preserve live cultures without further that could reduce viability. This process ensures the product's semi-liquid consistency and extended under , typically 30-45 days.

Variants and Packaging

Actimel products are packaged in small, single-serve bottles containing 100 g of the cultured drink, designed for easy consumption and . These bottles are primarily distributed in multipacks of 8 or 12 units, with larger family or bulk options available in 10- or 24-packs to accommodate household use. In 2023, removed labels from these small bottles in the for most variants to reduce material and environmental footprint, with exceptions for children's, plant-based, and select single-flavor products. The product lineup includes several ranges tailored to different consumer needs. The core range features plain and fruit-infused flavors such as original, , multifruit (combining , , , and ), , and cranberry-redcurrant-rosehip. Specialized variants encompass 0% fat and no-added-sugar options, frequently in flavor, alongside fruit-and-vegetable shots launched in 2019, including mango-orange-peach-mandarin with carrot-turmeric and apple-kiwi-pear with cucumber-spinach-spirulina-mint. Additional lines include the Triple Action range, enriched with vitamins C and magnesium beyond the standard D and B6 for antioxidant and anti-fatigue benefits; dairy-free plant-based alternatives; and kids' formulations with adjusted cultures and vitamins. These variants maintain the signature L. casei cultures while adapting to dietary preferences and nutritional goals, available across 26 countries.

Historical Development

Origins and Research

Actimel originated from research conducted by Danone in the 1980s, focusing on developing a fermented milk product incorporating a specific strain of Lactobacillus casei selected for its probiotic potential. The company isolated and cultured this strain, designated L. casei DN-114001 (also CNCM I-1518), through internal screening processes aimed at identifying bacteria with enhanced survival in the digestive tract and beneficial interactions with human microbiota. Early formulation efforts emphasized a slow fermentation process exceeding eight hours to optimize the strain's viability and the product's texture, laying the groundwork for a drinkable yogurt format distinct from traditional yogurts. Initial research on L. casei DN-114001, primarily conducted by Danone's R&D teams, demonstrated the strain's acid and bile resistance, enabling gastrointestinal transit and temporary colonization in the human gut. In vitro studies from the pre-launch period showed the strain's capacity to inhibit pathogen adhesion to intestinal cells, such as Escherichia coli, suggesting mechanisms for reducing infection risk through competitive exclusion and immune modulation. These findings, derived from laboratory models rather than large-scale human trials at the outset, informed the product's positioning for digestive and immune support, though subsequent independent evaluations have questioned the generalizability of early company-led data due to potential methodological limitations in probiotic strain selection and efficacy attribution. The culmination of this developmental research led to Actimel's commercial introduction in 1994, initially in Europe as a vitamin-enriched probiotic shot targeting everyday immune resilience, with the strain's proprietary status protected under Danone's intellectual property. While foundational studies provided evidence of the strain's survival and basic antagonistic effects against pathogens, broader clinical validation emerged post-launch, highlighting the need for rigorous, independent replication to substantiate causal links between consumption and health outcomes beyond preliminary observations.

Launch and Global Expansion

Actimel was first launched in in 1994 by as a fermented drink featuring the L. casei strain, developed through research into slow-fermentation processes spanning over eight hours to enhance probiotic viability. The product was positioned as a daily immune support shot, building on earlier discoveries of the L. casei Danone culture in 1990 and initial fermented milk research from 1987. Initial rollout emphasized its compact bottle format and health-focused formulation, targeting consumers seeking convenient intake. Expansion began rapidly within , with introduction to in 1995 and the and in 1999, where the iconic small bottles gained quick popularity. By 2000, Actimel had entered 20 countries, driven by Danone's marketing emphasis on immunity benefits and distribution through major retailers. This period marked the brand's transition from a regional novelty to a staple in aisles, supported by production scaling at facilities like the Rotselaar plant in . Subsequent global growth solidified Actimel's presence, reaching over 26 countries by the 2020s and establishing it as Europe's leading dairy immune support product. Key milestones included sales exceeding €1 billion annually by 2006, reflecting sustained international demand amid rising awareness. Expansion strategies involved localized variants and partnerships, though primary markets remained and select Asia-Pacific regions, with adaptations like added vitamins in 2010 to align with nutritional trends.

Recent Product Innovations

In September 2024, launched Actimel+ Triple Action, a fortified variant of its yogurt drink marking the product's 30th anniversary. This innovation builds on the original formulation by incorporating vitamins B6, C, and D alongside magnesium, while retaining billions of L. casei cultures per serving to target nutritional deficiencies common in European populations. The added nutrients support specific physiological functions: and B6 contribute to normal operation, magnesium helps reduce tiredness and , and provides effects, with each shot delivering 100% of the recommended daily intake. Available in flavors such as peach-passion fruit, strawberry-pomegranate, and blueberry-blackberry, the range contains 10 billion L. casei cultures and excludes artificial flavors, colors, or preservatives. Rollout began progressively across 20 European countries, including , the , , , and , with production in and . Danone positions this as an advancement in gut health and immunity support, addressing consumer demands for multifunctional dairy products amid rising awareness of shortfalls. Concurrently, has pursued packaging enhancements for the broader Actimel line, reducing weight by 40% since 1994 and eliminating labels on smaller bottles to save 868 tons of annually in . Larger formats in select markets, such as , incorporate 17% less through redesigned structures. These changes align with goals but do not alter the product's core composition.

Scientific Evaluation

Key Probiotic Strain

Lactobacillus casei DN-114 001, also designated CNCM I-1518, serves as the primary probiotic strain in Actimel, a fermented dairy product developed by Danone. This strain belongs to the species Lactobacillus casei, classified within the genus Lactobacillus (recently reclassified as Lacticaseibacillus casei in taxonomic updates), characterized as a Gram-positive, rod-shaped, catalase-negative, non-spore-forming bacterium. The strain exhibits facultative anaerobic growth, enabling proliferation in both oxygenated and low-oxygen environments such as the human gut, and demonstrates resilience to gastric acidity and bile salts, facilitating transit and potential colonization in the intestinal tract. These properties were identified through in vitro assessments showing higher survival rates under simulated digestive conditions compared to some other lactobacilli. Additionally, L. casei DN-114 001 produces lactic acid, contributing to an acidic microenvironment that may inhibit pathogenic bacteria. In Actimel formulations, L. casei DN-114 001 is co-cultured with traditional yogurt bacteria and Lactobacillus delbrueckii subsp. bulgaricus, distinguishing it from standard by the addition of this proprietary for targeted health applications. The strain's selection stemmed from Danone's research into strains with demonstrated gastrointestinal persistence, though its precise isolation origin—likely from fermented dairy—remains proprietary. Independent genomic analyses have confirmed its genetic stability and probiotic attributes, including adhesion to mucosal surfaces.

Evidence from Clinical Trials

Clinical trials investigating Actimel, a fermented drink containing the strain Lacticaseibacillus paracasei subsp. paracasei CNCM I-1518 (formerly casei DN-114001), have primarily focused on its potential to modulate immune responses and reduce the incidence or duration of infectious diseases, such as upper infections (URTIs). A (RCT) in elderly participants (n=428) consuming 100 g twice daily for three months reported a significant reduction in the mean duration of URTIs by approximately one day (from 9.4 to 8.4 days, p<0.05) compared to controls, alongside fewer episodes requiring antibiotics. Another RCT in children (n=428) found daily intake reduced the overall incidence of illnesses, though effects were modest and not uniform across all infection types. Trials on immune modulation include two studies showing enhanced antibody responses to influenza vaccination following regular consumption of the product; in one (n=60 healthy adults), geometric mean titers increased significantly for specific strains (p<0.05), suggesting improved humoral immunity. However, results for antibiotic-associated diarrhea (AAD) prevention are more consistent in targeted settings, with pooled data from two RCTs (n=approximately 200) yielding a relative risk reduction of 68% (RR=0.32, 95% CI 0.16-0.63). A systematic review and meta-analysis of nine RCTs (total n≈3,825-4,585, spanning children to adults) assessed effects on common infectious diseases (CIDs, including URTIs, lower respiratory, and gastrointestinal infections). It reported a reduced odds of experiencing at least one CID (OR=0.81, 95% CI 0.66-0.98, p=0.029) and fewer mean CIDs per subject (-0.09, 95% CI -0.15 to -0.04, p=0.001), with borderline relative risk for cumulative incidence (RR=0.91, 95% CI 0.82-1.01, p=0.082). No significant impacts were found on CID duration or severity (OR=0.99, 95% CI 0.54-1.81 for severe cases). Heterogeneity was low to moderate (I²=0-76%), but many included studies were industry-funded by Danone, raising concerns about potential sponsorship bias, and overall evidence quality varied (three high-quality, six fair/poor). Broader context from general probiotic reviews, including Cochrane analyses, indicates probiotics may prevent URTIs (RR≈0.81 across strains), but effects are strain-specific, with low to very low evidence quality due to risk of bias and inconsistency. For L. paracasei CNCM I-1518 specifically, benefits appear limited to modest incidence reductions in vulnerable groups like the elderly, without robust replication for immune enhancement or broad efficacy claims. Independent verification remains limited, as most trials originate from or are supported by the manufacturer.

Independent Reviews and Limitations

A 2020 systematic review and meta-analysis of randomized controlled trials on a fermented dairy drink containing Lacticaseibacillus paracasei CNCM I-1518 (formerly Lactobacillus casei DN-114001), the key strain in Actimel, found modest reductions in the duration of upper respiratory tract infection symptoms among consumers, with a pooled mean difference of -0.55 days (95% CI -0.99 to -0.11), but no significant effect on infection incidence. However, the review highlighted high heterogeneity (I²=88%) and reliance on industry-sponsored studies, limiting generalizability. Independent evaluations of probiotic efficacy for antibiotic-associated diarrhea (AAD) have shown variable results for the strain; a 2018 network meta-analysis indicated L. casei strains, including DN-114001, reduced AAD risk (RR 0.04, 95% CI 0.00-0.77 for Clostridium difficile-associated cases), but evidence quality was low due to small sample sizes and inconsistent comparators. Conversely, a 2007 clinical trial reported no preventive benefit against radiation-induced diarrhea, with incidence rates of 52% in the probiotic group versus 48% in controls (p>0.05). Limitations in the evidence base include heavy dependence on manufacturer-funded , which comprised over 70% of trials in a 2018 strain-specificity , potentially introducing sponsorship toward positive outcomes. Many studies suffer from short durations (typically 4-12 weeks), inadequate powering for rare endpoints, and failure to replicate benefits in diverse populations beyond cohorts. Broader critiques, such as a 2009 assessment, rejected general claims due to insufficient causal linking strains like DN-114001 to immune enhancement or prevention in healthy adults. Strain-specific effects are not consistently transferable, and viability post-digestion remains unproven in many formulations, undermining efficacy claims.

Health Claims and Regulation

Danone promotes Actimel, a fermented dairy drink, primarily for its role in supporting immune health through the inclusion of specific vitamins and probiotic cultures. The product is marketed as containing vitamins D and B6, which contribute to the normal function of the immune system, alongside billions of live cultures of the proprietary Lactobacillus casei DN-114 001 strain (also known as L. casei imunitass). Certain variants, such as the Actimel + Triple Action range, emphasize additional nutritional benefits: to aid immune support, for its antioxidant properties that protect cells from , and magnesium to help reduce fatigue and tiredness. These claims align with approved nutrient function assertions under regulations, focusing on the established physiological roles of these vitamins and minerals rather than unsubstantiated probiotic-specific effects. Historically, prior to regulatory adjustments in the late and early , advertised Actimel more aggressively for bolstering the body's natural defenses against infections, such as reducing the incidence of common colds, based on studies involving the L. casei strain. However, following (EFSA) evaluations and subsequent withdrawals of certain applications in 2010, promotional emphasis shifted away from direct probiotic-immunity links toward vitamin-centric messaging to comply with stricter substantiation requirements.

Regulatory Approvals and Rejections

In the , health claims for Actimel, containing the strain Lactobacillus casei DN-114 001, have faced repeated scrutiny and rejection by the (EFSA). In December 2010, EFSA concluded that evidence was insufficient to substantiate a claim that consumption of Actimel reduces the risk of Clostridium difficile-associated by lowering C. difficile toxins in the gut, deeming the provided human intervention studies inadequate to establish causality. contested this rejection, arguing it was "incomprehensible," but the claim was not approved under EU Regulation (EC) No 1924/2006 on nutrition and health claims. Similarly, proposed claims linking Actimel to enhanced immunity or reduced duration of respiratory infections were withdrawn by in 2010 after EFSA's preliminary assessments indicated insufficient substantiation, marking the second such withdrawal for the product. EFSA's evaluations highlighted methodological flaws in Danone-submitted trials, such as small sample sizes, lack of strain-specific effects, and failure to demonstrate consistent benefits across populations, leading to no authorized health claims for Actimel's probiotic effects to date. In the , the Advertising Standards Authority upheld complaints against Actimel advertisements in 2008, requiring revisions for implying unsubstantiated immune benefits, aligning with broader regulatory pressures. voluntarily removed immunity-related claims from Actimel packaging in by April 2010 amid these challenges. In the United States, where Actimel is marketed as DanActive, the (FDA) has not approved specific health claims for the product's strain. In 1999, the FDA warned Dannon that DanActive could not make structure/function claims implying disease prevention or treatment, such as bolstering immunity against colds, without meeting drug approval standards. While L. casei strains, including DN-114 001, are (GRAS) for use in food, no qualified health claims for reducing infection risk or gastrointestinal issues have been authorized by the FDA, reflecting the agency's stringent requirements for efficacy evidence.

Advertising and Legal Challenges

Actimel's advertising campaigns have frequently emphasized the probiotic benefits of its Lactobacillus casei strain (now branded as L. casei DN-114 001), claiming enhancements to immune function and protection against infections, which prompted regulatory interventions in multiple jurisdictions. In the United Kingdom, the Advertising Standards Authority (ASA) has repeatedly ruled against Danone for misleading claims, citing insufficient evidence to substantiate the advertised effects. In November 2006, the deemed an Actimel television advertisement misleading after it implied the product could prevent children from contracting bacterial infections, such as those causing ear or throat issues. The ruling highlighted that while Danone provided studies on the probiotic's general effects, they did not demonstrate prevention of specific bacterial illnesses in children, violating codes on substantiation and claims. Danone was instructed to ensure future ads did not make unsubstantiated implications about infection prevention. A March adjudication required to withdraw or amend another Actimel TV advert deemed misleading, as it exaggerated the product's role in bolstering immunity without adequate trial evidence linking consumption to reduced illness duration or severity in the general . This followed complaints that the claims overstepped the limited scope of supporting , which primarily involved small-scale or studies rather than broad protective effects. The most prominent challenge occurred in October 2009, when the banned a nationwide campaign asserting that Actimel was "scientifically proven" to help support children's natural defenses against disease. The concluded the ad breached rules on misleading , requirements, and food claim accuracy, as Danone's submitted trials—often industry-funded and focused on adults or specific markers like levels—failed to prove clinically relevant benefits for children against everyday threats like colds or flu. defended the claims by referencing over 20 studies, but regulators found the insufficient for the promotional phrasing, leading to the ad's prohibition and a directive to avoid similar unsubstantiated assertions. Beyond the UK, European Union regulations amplified these issues; in April 2010, Danone voluntarily withdrew health benefit claims for Actimel following rejections by the (EFSA), which scrutinized probiotic assertions under stricter substantiation standards introduced in 2006. The company cited alignment with evolving EU rules on and claims, though critics noted the move avoided further regulatory penalties amid growing skepticism over probiotic efficacy in fortified foods. In , where Actimel is marketed as DanActive, parallel class-action lawsuits settled in 2010 resulted in paying up to $45 million to consumers for allegedly exaggerated digestive and immune claims, underscoring similar evidentiary shortfalls in . These challenges reflect broader regulatory pressures on probiotics, where promotional language often outpaces the causal evidence from randomized trials, which typically show modest or context-specific effects rather than universal protection.

Commercial and Marketing Aspects

Strategies and Positioning

Actimel employs a differentiation strategy that positions the product as a specialized drink bridging the gap between functional health benefits and enjoyable consumption, carving out a distinct for immunity-focused fermented shots. Unlike traditional yogurts emphasizing taste or nutrition alone, Actimel highlights its fermented base fortified with Lactobacillus casei DN-114 001 and vitamins D and B6 to support daily immune resilience, targeting health-conscious adults seeking convenient, science-backed wellness aids. The brand's core positioning revolves around making Actimel "synonymous with immunity," encouraging habitual integration into routines via seasonal campaigns that amplify perceived protective effects during peak vulnerability periods like cold and flu seasons. This is reinforced through approaches combining awareness drives with targeting, such as YouTube's "moment " to deliver resilience-themed ads during user low-energy moments, achieving higher view-through rates and among younger demographics traditionally underserved by the product. To broaden appeal, has tailored positioning for niche audiences, including "Actimel for Kids" variants aimed at parents prioritizing child immunity with milder flavors and child-specific formulations launched in , and experimental metaverse integrations in platforms like to engage adult gamers as emerging health seekers. Recent efforts, such as the 2023 "Little Daily Habits" campaign, position Actimel as an unmissable morning ritual for shoppers via integrated paid, earned, out-of-home, and shopper , fostering loyalty among over 1 million households by linking small actions to broader health empowerment. Real-time tactics, including activations across , further adapt positioning to cultural events, enhancing relevance and engagement without diluting the immunity core.

Market Performance and Sales

Actimel maintains a dominant position in the European yogurt drink market, particularly in the dairy immune support shot segment. According to Nielsen sales volume data for 2023, the brand leads this category in multiple countries, including , , the , , , , and . In the , Actimel ranks as the leading brand among drinks and cold milk drinks based on consumer reach as of October 2025, with an estimated high volume of regular consumers reported in 2022 surveys. The brand's performance aligns with broader growth in 's Essential Dairy and Plant-based Products division, which encompasses Actimel. Danone reported like-for-like sales growth of 4.3% for the full year 2024, driven by 3.0% volume/mix expansion, with executives highlighting Actimel's strong traction in early 2024 earnings discussions. This continued into 2025, with like-for-like sales up 4.3% group-wide, supported by category demand for functional dairy products. Specific for Actimel remains undisclosed in public filings, but its category leadership has historically boosted divisional results, as noted in prior performance reviews. Market expansion efforts, including product innovations like reduced-plastic packaging and new formulations launched in , have sustained Actimel's competitive edge amid a growing global probiotic drinks sector valued at USD 49.5 billion in . In the UK probiotic market, drinks like Actimel captured 57.21% share in , reflecting robust category penetration.

Controversies and Criticisms

Efficacy Skepticism

Skepticism regarding Actimel's efficacy stems primarily from the modest and context-specific nature of supporting evidence, contrasted with broad marketing claims of general enhancement. Multiple clinical trials funded by have reported reductions in respiratory infection incidence or duration among children or vulnerable groups consuming the product containing Lacticaseibacillus casei DN-114 001, such as a 22% lower illness rate in a randomized trial of 428 children. However, these studies often involve small sample sizes, short durations, and company sponsorship, raising concerns about and generalizability to healthy adults. Independent meta-analyses indicate that effects on immunity are strain- and disease-specific, with limited high-quality evidence for broad benefits in asymptomatic populations. Regulatory scrutiny has underscored these limitations. In 2010, the U.S. charged with making unsubstantiated claims that DanActive (Actimel's U.S. equivalent) was "clinically proven" to reduce illness risk by 24% or boost immunity, leading to an agreement to drop such assertions and pay redress. Similar class-action settlements followed, including a $45 million payout in 2010 for misleading and a $1.7 million Canadian settlement in 2012 challenging immunity and digestion benefits. In the UK, the Advertising Standards Authority banned Actimel ads in 2008 and 2009 for implying unproven health defenses against external agents. The has rejected general immunity claims for this strain, citing insufficient evidence from human trials. These actions highlight that promotional narratives often exceed verifiable causal effects, particularly absent large-scale, independent replication. Cochrane reviews on for upper infections suggest a potential modest reduction in occurrence (risk ratio 0.81), but with low certainty due to heterogeneity, risks, and applicability limited to specific strains rather than drinks like Actimel. Critics note that while the strain may aid antibiotic-associated prevention in targeted scenarios, broad immunity boosting lacks robust, unbiased support, as survival of live cultures through and remains inconsistent across individuals. Overall, first-principles evaluation reveals ' mechanisms—such as transient gut modulation—do not reliably translate to systemic immune enhancement in healthy users, prioritizing empirical caution over extrapolated benefits.

Ethical and Consumer Issues

Actimel has drawn consumer criticism for its high content, with many variants containing 10 to 13 grams of per 100 milliliters, levels comparable to or exceeding those in some soft drinks despite its positioning as a health-oriented product. This has led to accusations that the product's nutritional profile undermines its marketed benefits, potentially misleading health-conscious buyers into over-relying on it for immunity or digestive support without addressing dietary intake. In September 2024, Danone elected to remove Nutri-Score labels from Actimel and related brands in several European markets, a move attributed to the products' poor performance under the system—often scoring C or lower due to elevated sugar and limited nutritional density—which critics argue prioritizes marketing over nutritional transparency and consumer empowerment. Consumer reviews on platforms like Trustpilot reflect mixed satisfaction, with some complaints centering on perceived value for price given unverified health outcomes and palatability issues in certain flavors. On ethical grounds, Actimel, as a brand, scores below ethical benchmarks in assessments of producers, particularly for standards in sourcing, where practices raise concerns over conditions and use. Environmental critiques highlight the industry's contributions to and water usage, though has pursued incremental improvements like lighter for Actimel bottles in 2023 to enhance recyclability. ethics, including labor practices in global operations, further contribute to Danone's low ratings from organizations evaluating corporate responsibility.

References

  1. [1]
    Actimel dairy immune support shots | Danone Group
    Actimel contains vitamins D and B6 to support the immune system and billions of exclusive L.casei cultures.
  2. [2]
    Actimel - The cultured yogurt shot that's got a lot | Actimel
    Actimel is a tasty cultured yogurt shot packed with L.casei cultures and vitamins D and B6 which help support your immune system.Original · FAQs · Actimel Original Yogurt Drink... · Actimel Immunity Report 2022Missing: definition | Show results with:definition
  3. [3]
    Our story | Actimel
    Actimel power shot is introduced​​ The iconic Actimel bottles are launched in Belgium, followed by the UK and Ireland in 1999. The world quickly takes this dinky ...
  4. [4]
    Commercially available probiotic drinks containing Lactobacillus ...
    A commercially available probiotic drink containing Lactobacillus casei DN 114001 cost-efficiently reduces the prevalence of AAD during antibiotic treatment.Missing: immunitas | Show results with:immunitas
  5. [5]
    Lactobacillus casei DN-114 001 plus yoghurt symbiosis and ... - EFSA
    Dec 8, 2010 · The Panel concludes that the evidence provided is insufficient to establish a cause and effect relationship between the consumption of Actimel® ...Missing: immunitas | Show results with:immunitas
  6. [6]
    Probiotic health claims ruled unproven - The Guardian
    Oct 19, 2010 · Danone, the market leader in probiotic products, withdrew its claims that Actimel and Activia boosted the immune system and aided digestive ...
  7. [7]
    Danone's Actimel ad misleading, says UK watchdog - Dairy reporter
    Nov 2, 2006 · The advert wrongly implied that Danone's popular Actimel product could help prevent children from catching bacterial infections, said the UK ...
  8. [8]
    Does the scientific evidence support the advertising claims made for ...
    The evidence for L. casei is null, while only four studies support the health claims made for B. lactis. We conclude that the company's advertisements for its ...Introduction · Methods · Results · DiscussionMissing: immunitas | Show results with:immunitas
  9. [9]
    A Unique Mix of Ingredients - Actimel
    Actimel is a cultured yogurt shot full of live cultures and it contains vitamins D and B6 to help support the immune system. Discover our ingredients.
  10. [10]
    Use of a fermented dairy probiotic drink containing Lactobacillus ...
    May 19, 2010 · ... Actimel), a probiotic dairy drink, available in grocery stores in many countries worldwide. Earlier published clinical trials have found ...
  11. [11]
    Actimel Original Yogurt Drink 8 x 100g (800g) - Spoonful App
    Ingredients: Yogurt (Milk), Skimmed Milk, Sugar / Liquid Sugar, Dextrose, Milk Minerals Concentrate, Lactobacillus Casei (L. Casei Danone®), Vitamins (B6, D)
  12. [12]
    https://www.tesco.com/groceries/en-GB/products/259050439
  13. [13]
    Actimel Original Cultured Yogurt Shot
    Nutritional Information ; Energy. 303kJ 72kcal. 4% ; Fat. 1.5g · 4% ; Saturates. 1.0g · 5% ; Sugars. 11g · 12% ; Salt. 0.10g · 2%.Strawberry · Multifruit · Blueberry · Core range
  14. [14]
    actimel - Open Food Facts
    Jul 7, 2023 · 30 ingredients: yogurt (milk), skimmed milk, sugar/liquid sugar, fruit juice from concentrate (2.1%) (pineapple, peach, orange, strawberry), oligofructose ( ...
  15. [15]
    https://zoom.ocado.com/actimel-original-0-added-sugar-fat-free-yoghurt-drink-8-x-100g-12240011
  16. [16]
    https://www.tesco.ie/groceries/en-IE/products/256572206
  17. [17]
    Actimel Multifruit Family Pack 10 x 100g (1kg) - Amazon UK
    In stock Rating 4.5 (5) Danone Actimel Multifruit Drink 12X100gr x 2 pack. 4.7 out of 5 stars ; Actimel Strawberry 4 x 100g (400g). 3.6 out of 5 stars ...
  18. [18]
    Actimel Multifruit Immunity Yoghurt Drink Multipack, 100g - Brakes
    In stockActimel Multifruit Immunity Yoghurt Drink Multipack, 100g. Pack size: 24 x 100g. Offer. icon-E55 icon-E24. Add to favourites. Pack size: 24 x 100g. Add.
  19. [19]
    Danone caps 30 years of gut health innovation with Actimel+ Triple ...
    Oct 2, 2024 · The new yogurt shot is fortified with vitamins B6, C and D as well as magnesium to address common nutritional shortfalls, Danone told us.
  20. [20]
    Actimel Multifruit Cultured Yogurt Shot
    Switch up your day with the delicious yoghurty taste of pineapple, peach, orange and strawberry. A small but fruity beauty. The whole Actimel Core range is ...
  21. [21]
    Cranberry, Redcurrant, Rosehip | Actimel
    Original · Strawberry · Multifruit · Blueberry · Cranberry Redcurrant Rosehip ...
  22. [22]
    Actimel Fruit & Veg Cultured Shots - Packaging Of The World
    Aug 23, 2019 · Mango, orange, peach, mandarin, carrot and turmeric; Apple, kiwi, pear, cucumber, spinach, spirulina and mint. All 3 flavours are with no added ...Missing: variants flavors
  23. [23]
    0% added sugar 0% fat strawberry Actimel – Danone – 800 g
    Nov 12, 2014 · Common name: Yogurt drink with L. casei Danone cultures, vitamins B6 and D, strawberry and with sweeteners. Quantity: 800 g.Missing: formats | Show results with:formats
  24. [24]
    ACTIMEL - Danone
    Actimel is a delicious probiotic dairy product. It contains 10 billion exclusive L. casei cultures, Vitamins B6 and D3 in every bottle.Missing: types formats
  25. [25]
    [PDF] DANONE - Activia® Gut Health Toolkit
    Danone Nutricia Research and collaborators from UCLA11 published the first gut–brain probiotic clinical trial with Activia. 2013. Danone North America and ...Missing: initial | Show results with:initial<|control11|><|separator|>
  26. [26]
    Survival of Lactobacillus casei in the Human Digestive Tract after ...
    The probiotic strain Lactobacillus casei DN-114 001 (CNCM number I-1518) reduces the frequency or the duration of epi- sodes of acute diarrhea in young ...Missing: discovery | Show results with:discovery
  27. [27]
    Lactobacillus casei DN-114 001 Inhibits the Ability of Adherent ... - NIH
    The aim of this study was to determine the in vitro inhibitory effects of the probiotic strain, Lactobacillus casei DN-114 001, on adhesion to and invasion of ...Missing: discovery | Show results with:discovery
  28. [28]
    Probiotic products from laboratory to commercialization
    The transfer of probiotic products aims to improve public health for example products like Jiangshui yogurt, Actimel, and GoodBelly claim to reduce ...
  29. [29]
    Use of a fermented dairy probiotic drink containing Lactobacillus ...
    May 19, 2010 · Daily intake of a fermented dairy drink containing the probiotic strain L. casei DN-114 001 showed some promise in reducing overall incidence of illness.
  30. [30]
    Danone Celebrates 30 Years of Pioneering Product in Spain
    Sep 19, 2025 · Debuting in 1995, Actimel was revolutionary for its use of fermented milk with probiotics (L. casei) and its catchy slogan "Activate your ...
  31. [31]
    Why Danone is becoming a flexitarian company - RetailDetail EU
    The Rotselaar plant wrote the first chapter in Actimel's history, already in 1994, and now produces the drink for consumers throughout Europe. A strategically ...<|separator|>
  32. [32]
    [PDF] PERFORMANCE
    In 2006, for the first time, two brands—Activia and Actimel—each recorded over €1 billion in sales. FDP operating profit also reach €1 billion.Missing: timeline | Show results with:timeline
  33. [33]
    Global Probiotics Market 2019-2024 with Nestle, Danone, and ...
    Jun 26, 2019 · The probiotics market witnessed dominance from the giants, Nestle, Danone, and Yakult. Actimel, Activia, and Yakult are the world's top brands ...
  34. [34]
    Danone launches fortified Actimel+ Triple Action range - The Grocer
    Sep 17, 2024 · The range has been fortified with vitamins D and B6, to support the normal function of the immune system, magnesium to reduce tiredness and vitamin C.Missing: 2023 | Show results with:2023
  35. [35]
    Danone expands Actimel portfolio with latest launch - FoodBev Media
    Danone has launched a new immune-boosting range of shots under its Actimel brand, containing 100% of the recommended intake of vitamin D.Missing: 2024 | Show results with:2024
  36. [36]
    Lactobacillus casei DN-114001 | Database - Optibac Probiotics
    May 22, 2020 · Lactobacillus casei DN-114001 is a strain which is often found in yoghurt drinks purchased in supermarkets and consumed by the general population.Missing: discovery | Show results with:discovery
  37. [37]
    Scientific Opinion on the substantiation of a health claim related to ...
    was asked to deliver an opinion on the scientific substantiation of a health claim related to a fermented milk drink. Actimel® containing Lactobacillus casei ...Missing: immunitas | Show results with:immunitas
  38. [38]
    [PDF] In Vitro assessment of the survivability of Lactobacillus casei DN ...
    Dec 1, 2012 · casei DN-114 001 both exhibited high tolerance to gastric and duodenal digestion and furthermore, both strains exhibited higher survival rates ...
  39. [39]
    Lacticaseibacillus Casei – Uses, Side Effects, and More - WebMD
    Lacticaseibacillus casei (L. casei) is a type of probiotic ("good" bacteria) found in the infant digestive tract. It produces lactic acid in the gut.
  40. [40]
    The influence of Lactobacillus casei DN 114 001 on the activity of ...
    Lactobacillus casei DN 114 001 is a well-known commercial probiotic strain (the Actimel strain from Danone). It possesses probiotic properties, but little ...<|separator|>
  41. [41]
    Comparative Genomic and Functional Analysis of Lactobacillus ...
    One of the most studied and widely marketed probiotic strain is the human isolate L. rhamnosus GG (commercialized under the name LGG). We have recently ...
  42. [42]
    Consumption of a fermented dairy product containing the probiotic ...
    Sep 14, 2009 · Consumption of a fermented dairy product containing the probiotic strain L. casei DN-114 001 in elderly was associated with a decreased duration of CID.
  43. [43]
    A probiotic fermented dairy drink improves antibody response to ...
    The aim of the clinical studies reported here was to investigate the effect of regular consumption of the probiotic drink Actimel® on the specific antibody ...
  44. [44]
    Strain-Specificity and Disease-Specificity of Probiotic Efficacy
    Dietrich et al. compared two similar commercial products (Actimel® with L. casei DN-114001 and Yakult® with L. casei Shirota) for the ...
  45. [45]
    Effects of a Fermented Dairy Drink Containing Lacticaseibacillus ...
    Three sets of search terms were used to identify the exposure, health outcome, and study population. Exposure search terms comprised Actimel or fermented ...
  46. [46]
    Probiotics for preventing acute upper respiratory tract infections
    Aug 24, 2022 · Authors' conclusions. Overall, we found that probiotics were better than placebo or no treatment in preventing acute URTIs. PICOs ...
  47. [47]
    Comparative efficacy and tolerability of probiotics for antibiotic ...
    Mar 1, 2018 · With regard to reducing Clostridium difficile infection rate, Lactobacillus casei (L. casei ) was considered better efficacy (0.04 (0.00, 0.77)) ...
  48. [48]
    Effects of Probiotic Lactobacillus Casei DN-114 001 in Prevention of ...
    Conclusion. Nutritional intervention with the probiotic drink containing L. casei DN-114 001 does not reduce the incidence of radiation-induced diarrhea as ...
  49. [49]
    Strain-Specificity and Disease-Specificity of Probiotic Efficacy
    One strain (L. casei DN-114001) was significantly more effective in reducing AAD incidence than the other L. casei strain (6.7 and 33.3%, respectively, p < ...
  50. [50]
    Health claim of probiotics not accepted | The Independent
    Oct 2, 2009 · But claims that probiotic ingredients improve health can not be supported, according to an extensive review of scientific research by a team of ...<|separator|>
  51. [51]
    Danone resubmits Actimel probiotic immunity health claim
    Feb 10, 2010 · The dossier contains about 20 studies that demonstrated the benefits of Actimel.Missing: immunitas | Show results with:immunitas<|separator|>
  52. [52]
    Danone to withdraw ads claiming yoghurt's health benefits - France 24
    Apr 16, 2010 · French food industry giant Danone will withdraw their ads claiming yogurt brands Activia and Actimel have specific health benefits.
  53. [53]
    Danone: EFSA Actimel diarrhoea claim rejection is "incomprehensible"
    Dec 9, 2010 · Danone will contest the diarrhoea health claim rejection for its Actimel drinking yoghurt handed to it by the European Food Safety Authority this week.
  54. [54]
    Danone withdraws marquee probiotic health claims (again)
    Apr 15, 2010 · The Actimel immunity claim was only resubmitted by Danone two months ago while its Activia gut health claim was re-entered late in 2009. Both ...
  55. [55]
    Danone cautioned over UK Actimel adverts - Dairy reporter
    Jun 11, 2024 · In 2006, another Actimel advert implying it could help prevent children from catching bacterial infections, was deemed inappropriate by the ASA.
  56. [56]
    https://news.bbc.co.uk/2/hi/8622017.stm
  57. [57]
    Dannon Actimel Yogurt Drink May Not Make Structure/Function Claims
    Sep 20, 1999 · Dannon Actimel Yogurt Drink May Not Make Structure/Function Claims - FDA ... Dannon's Actimel yogurt breakfast drink with live L. casei culture is ...
  58. [58]
    The Lactobacillus casei Group: History and Health Related ...
    Sep 10, 2018 · Their long history of use in fermented products has led to their recognition as GRAS (generally recognized as safe) by the US Food and Drug ...
  59. [59]
    UK censors Danone probiotic TV ads - NutraIngredients.com
    Mar 18, 2017 · In 2006, another Actimel advert implying it could help prevent children from catching bacterial infections, was deemed inappropriate by the ASA.Missing: challenges | Show results with:challenges
  60. [60]
    'Healthy' yogurt advert banned - Home - BBC News
    Oct 14, 2009 · In the end, the ASA ruled that the advert was misleading and broke rules in relation to evidence and accuracy in advertising.Missing: legal challenges
  61. [61]
    Actimel no longer “scientifically proven” - Marketing Week
    Oct 14, 2009 · In the ad's defence, Danone UK said that the health benefits of Actimel had been demonstrated in 23 human studies conducted over 6,000 people ...Missing: controversies | Show results with:controversies
  62. [62]
    Actimel advert banned for being 'misleading' | Express.co.uk
    Oct 14, 2009 · The ASA concluded the ad must be banned as it broke rules for being misleading, rules relating to evidence and accuracy in food advertising.
  63. [63]
    EU health food claims law begins to bite - BBC News
    Jul 7, 2010 · "EFSA is rejecting most of the proposed food supplement claims," says Jenny Baillie of the York-based health foods company Power Health ...
  64. [64]
    Danone Pulls Yogurt Health Claims - SupplySide Supplement Journal
    In March, a U.S. district judge ordered the company to pay consumers up to $45 million in damages under the terms of a class-action settlement reached in ...Missing: benefits | Show results with:benefits
  65. [65]
    Marketing Strategies of Danone: One Planet. One Health
    Aug 4, 2023 · For instance, the Actimel campaign emphasizes the product's immunity-boosting properties during the cold and flu season, resonating with health ...
  66. [66]
    Actimel Moment Marketing: Helping Users Stay Strong via YouTube
    To address these challenges, Actimel designed a two-part strategy. First, the brand launched a large traditional awareness campaign involving two TV ads.
  67. [67]
    https://www.thetradedesk.com/case-studies/omnichannel-vs-multichannel-how-danone-actimel-boosted-full-funnel-metrics
  68. [68]
    [PDF] Actimel Moment Marketing: Helping users stay strong via YouTube
    To address these challenges, Actimel designed a two-part strategy. First, the brand launched a large traditional awareness campaign involving two TV ads.
  69. [69]
    Danone targets adult gamers with move towards the metaverse
    Apr 12, 2023 · The decision to market Actimel within the Fortnite ecosystem was influenced by a desire to reach adult gamers and encourage market engagement. “ ...Missing: positioning | Show results with:positioning
  70. [70]
    Danone targets children and parents with Actimel for Kids launch
    Aug 11, 2014 · Danone has launched a new range of its Actimel yoghurt drink aimed specifically at the health drink company's younger consumers.Missing: positioning | Show results with:positioning
  71. [71]
    Actimel launches integrated Little Daily Habits campaign spanning ...
    Jan 17, 2023 · Health seekers will be encouraged to adopt Actimel as a little daily habit by being unmissable in key channels – from appearing in their morning ...
  72. [72]
    How did Danone use Twitter to reposition Actimel in Europe thanks ...
    Strategy. For its Actimel brand, Danone established a communication strategy on Twitter, based on real-time marketing in several European countries. The brand ...
  73. [73]
    https://www.statista.com/statistics/308668/leading-yogurt-drinks-and-cold-milk-drinks-brands-in-the-uk/
  74. [74]
    https://www.statista.com/statistics/311720/danone-leading-producs-in-the-uk/
  75. [75]
    Full-Year Results 2024 - Danone
    FY 2024 sales of €27,376m up +4.3% on a like-for-like (LFL) basis, with volume/mix up +3.0%, and price up +1.3%. Q4 sales up +4.7% LFL, with strong volume/mix ...
  76. [76]
    [PDF] DANONE FIRST QUARTER SALES 2024 CONFERENCE CALL ...
    Apr 18, 2024 · We are particularly happy with the performance of brand platforms like High Protein as well as Actimel, but also increasingly good traction on ...
  77. [77]
    H1 Results 2025 - Danone
    H1 2025 sales of €13,737m up +4.2% on a like-for-like (LFL) basis, with volume/mix up +2.6%, and price up +1.7%. Q2 sales up +4.1% LFL, with strong ...
  78. [78]
    Probiotic Drinks Market Size & Share, Growth Trends 2025-2034
    The global probiotic drinks market was valued at USD 49.5 billion in 2024, with expectations to reach USD 116.9 billion by 2034, growing at a CAGR of 9%.
  79. [79]
    UK Probiotics Market - Size, Share & Growth, Analysis
    Aug 28, 2025 · The probiotic drinks market has established a commanding position, securing a substantial 57.21% market share in 2024. This dominance stems from ...
  80. [80]
    Should everyone take a probiotic? Assessment of evidence of ...
    Jul 14, 2024 · The authors concluded, “…we did not find a high level of evidence to support recommendations for other endpoints we reviewed for healthy people.
  81. [81]
    Dannon Agrees to Drop Exaggerated Health Claims for Activia ...
    Dec 15, 2010 · The Commission also charged that Dannon's claims that Activia and DanActive were clinically proven were false. “These types of misleading ...
  82. [82]
    Dannon to Pay $45M to Settle Yogurt Lawsuit - ABC News
    Feb 26, 2010 · A judge in Cleveland this week says Dannon must pay consumers up to $45 million in damages under the terms of a class action settlement, reached in federal ...
  83. [83]
    Danone agrees to pay $1.7M in yogurt health claims case | CBC News
    Sep 25, 2012 · A Montreal woman initiated the lawsuit against Danone Inc. in 2009 contesting claims that its Activia, Activia Light yogurt and DanActive ...Missing: Actimel | Show results with:Actimel
  84. [84]
    UK: Danone accused of false Actimel claims - Just Food
    Oct 14, 2009 · A UK television advert for Danone's Actimel yoghurt has been banned by the advertising watchdog over false claims that the product provides health benefits to ...
  85. [85]
    Probiotics: Looking Underneath the Yogurt Label
    Sep 28, 2009 · The word “probiotic” on the label is not enough information to tell whether a given product will be effective for a particular health concern.<|control11|><|separator|>
  86. [86]
    Are probiotics really that good for your health? | Food - The Guardian
    Jul 24, 2009 · Consumer research showed that if they could claim in TV advertising that Actimel's Lactobacillus casei Imunitass worked to "balance the ...
  87. [87]
    Why did Danone decide to remove the Nutri-Score from its brands of ...
    Sep 21, 2024 · Danone made the consequential decision to abandon the display of the Nutri-Score on five of its brands (Actimel, Activia, Danino, Danone, Hi Pro)
  88. [88]
    Danone, 'health' claims on drinks full of added sugars - FoodTimes
    Jan 12, 2025 · Danone's 'nutrition and health claims' on milk and yogurt-based drinks with added sugars in quantities similar and even higher than Coca-Cola.
  89. [89]
    Danone Plans to Abandon Nutri-Score on Many of Its Products
    Sep 18, 2024 · Some of these products may contain 10 to 13 grams of sugar per 100 mililiters but were abnormally classified as ​'A' or ​'B' with the ...
  90. [90]
    Read Customer Service Reviews of www.actimel.co.uk - Trustpilot
    Rating 3.5 (19) 19 people have already reviewed Actimel. Read about their experiences and share your own!
  91. [91]
    Ethical Yoghurt - The Good Shopping Guide
    The brands that were recognised as substandard included Activia, Actimel, Alpro, Light & Free, Oykos and Provamel. These brands are all owned by Danone. Danone ...
  92. [92]
    15 ethical brands owned by unethical companies
    Dec 27, 2023 · From vegan brands owned by meat conglomerates to herbal tea companies owned by private equity firms with links to fossil fuels – we highlight ethical brands.
  93. [93]
    Actimel - Yoghurt: Ethical Sustainable Comparison
    Actimel is a brand of probiotic yoghurt drinks. It was created by Danone in 1994 after their 'discovery' of a culture they named L.casei Danone. In which ...
  94. [94]
    Actimel – sleeveless design means improved recyclability and less ...
    Jul 10, 2024 · Danone has taken strong commitments towards circular and low-carbon packaging. Actimel brand embodies this packaging transformation: in 2023, we ...Missing: ethics | Show results with:ethics